• Protocols

• NCI10558

  OPEN TO ACCRUAL

  Ph2 RCT Lutathera +/- Triapine in Somatostatin Receptor-Positive Neuroendocrine Tumors
  
  

• UW24025

  OPEN TO ACCRUAL

  A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors